City
Epaper

Madhya Pradesh reports first H3N2 infection, patient in home isolation

By ANI | Updated: March 17, 2023 05:45 IST

Bhopal (Madhya Pradesh) [India], March 17 : Madhya Pradesh Medical Education Minister Vishwas Sarang on Thursday confirmed that the ...

Open in App

Bhopal (Madhya Pradesh) [India], March 17 : Madhya Pradesh Medical Education Minister Vishwas Sarang on Thursday confirmed that the first case of H3N2 infection had been reported in the state capital, Bhopal.

He informed further that the patient has been kept in home isolation.

Seasonal influenza is an acute respiratory tract infection caused by 4 distinct types of viruses Influenza A, B, C and D belonging to the Orthomyxoviridae family.

Among these types, Influenza A is the most common pathogen for humans.

Globally, influenza cases are typically seen to increase during certain months of the year. India usually witnesses two peaks of seasonal influenza one from January to March and another one in the post-monsoon season.

According to the Union Health Ministry, the cases arising from seasonal influenza are expected to decline from March end.

In most cases, the disease is self-limiting with symptoms of cough and cold, body ache and fever etc. and usually resolves within a week or so.

However, potentially high-risk groups such as infants, young children, pregnant women, elderly above the age of 65 years and people with comorbidities might experience more symptomatic illnesses requiring hospitalization also.

Disease transmission is mostly airborne from person to person, through large droplets generated by the act of coughing and sneezing. Other modes of transmission, include indirect contact by touching a contaminated object or surface (fomite transmission), and close contact including handshaking.

The Union Health Ministry has prescribed Oseltamivir as the drug recommended by the World Health Orgzation (WHO) for curing the infection.

"The drug is made available through the Public Health System free of cost. The government has allowed the sale of Oseltamivir under Schedule H1 of the Drug and Cosmetic Act in February 2017 for wider accessibility and availability," it said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Madhya pradesh medical educationindiabhopalVishwas SarangUnion Health MinistryBhopal districtIndiUk-indiaRepublic of indiaIndia indiaGia india
Open in App

Related Stories

TechnologyHow To Effortlessly Transfer Data from Android to iPhone Using Apple’s Move to iOS App

NationalHarda Shocker: Govt Employee Dies by Suicide After Inhaling LPG Gas in Madhya Pradesh

NationalDonald Trump Imposes Additional 25% Tariff on India, Total Tariff Now 50%

TechnologyWill the Government Have to Offer More Incentives on EVs? NITI Aayog Raises Concerns Over Slow Sales Growth

NationalElephants Cause Havoc in Marwahi Forest Division, Destroying Homes and Instilling Fear Among Villagers

National Realted Stories

NationalPM Modi to lead 79th Independence Day celebrations with theme of 'Naya Bharat' at historic Red Fort today

NationalDharmasthala mass grave case: Decision to halt excavation will be taken by SIT, says K'taka govt

NationalAssam Rifles recovers drugs, Indian currencies in Mizoram; two held

NationalCong started 'vote theft', Sonia Gandhi became official voter when she was not Indian citizen: BJP leader

NationalBengal, Bengali made maximum contribution behind Freedom movement